Journal Article Epublish
PubMed: 42827857 DOI: 10.1016/j.ajpc.2026.101752
Efficacy and safety of alirocumab once-monthly in patients with atherosclerotic cardiovascular disease and without history of an acute atherothrombotic event.
Am J Prev Cardiol 30:101752
Authors: Lale Tokgözöğlu, Yaron Arbel, Clara Bonanad Lozano, Fabrice Martens, Ksenija Stach, Mattea Orsini, Hagai Tavori, Miguel Cainzos-Achirica, Tienush Rassaf, Pasquale Perrone-Filardi, Michal Vrablík
Affiliations
- Department of Cardiology, Hacettepe University Faculty of Medicine, Sıhhiye, 06100 Ankara, Turkey.
- Division of Cardiology, Gray Faculty of Medical & Health Sciences, Tel Aviv Sourasky Medical Center, 6 Weizmann St, 6423906 Tel Aviv, Israel.
- Cardiology Service, Hospital Clínico Universitario de Valencia, Av. de Blasco Ibáñez 17, 46010 Valencia, Spain.
- Department of Cardiology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Fifth Medical Department, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
- Aixial Group, 78 Grande Rue, Sèvres, 92310, France.
- Sanofi, 46 Avenue de la Grande Armée, 75017 Paris, France.
- Department of Cardiology, Hospital del Mar, and Universitat Pompeu Fabra, Pg. Marítim de la Barceloneta 25-29, 08003 Barcelona, Spain.
- Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, University Duisburg-Essen, Hufelandstraße 55, 45147 Essen, Germany.
- Department of Advanced Biomedical Sciences, Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy.
- 3rd Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 1, 128 08 SSS, Czech Republic.
MeSH
Safety, Cardiovascular Diseases, History